Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Penicillin-resistant pneumococci

Cefaclor, cefuroxime axetil, cefprozil, and loracarbef can be given orally. The usual dosage for adults is 10-15 mg/kg/d in two to four divided doses children should be given 20-40 mg/kg/d up to a maximum of 1 g/d. Except for cefuroxime axetil, these drugs are not predictably active against penicillin-resistant pneumococci and should be used cautiously, if at all, to treat suspected or proved pneumococcal infections. Cefaclor is more susceptible to 13-lactamase hydrolysis compared with the other agents, and its usefulness is correspondingly diminished. [Pg.992]

Disease that is segmental or lobar in its distribution is usually caused by Streptococcus pneumoniae (pneumococcus). Haemophilus influenzae is a rare cause in this group, although it more often leads to exacerbations of chronic bronchitis and does cause pneumonia in patients infected with HIV. Benzyl-penicillin i.v. or amoxicillin p.o. are the treatments of choice if pneumococcal pneumonia is very likely alternatively, use erythromycin/clarithromycin in a penicillin-allergic patient. Seriously ill patients are best given benzylpenicillin (to cover the pneumococcus) plus ciprofloxacin (to cover Haemophilus and atypical pathogens). Where penicillin-resistant pneumococci are prevalent, i.v. cefotaxime is a reasonable best guess choice. [Pg.240]

The first cases of peniciUin-resistant pneumococci were reported in the 1960s in New Guinea and Australia. Penicillin-resistant pneumococci have now been registered in all continents. The highest rate was reported in 1989 in Hungary, amounting to 57% of all clinical isolates... [Pg.489]

Garcia-Bustos J, Tomasz A. A biological price of antibiotic resistance major changes in the peptidoglycan structure of penicillin-resistant pneumococci. Proc Natl Acad Sci USA 1990 87(14) 5415-19. [Pg.500]

For community-acquired pneumonia, the bacterial causes are relatively constant, even across geographic areas and patient populations. Unfortunately, pathogen resistance to standard antimicrobials is increasing (e.g., penicillin-resistant pneumococci), necessitating... [Pg.1958]

Structural change in PBPs (eg, methicillin-resistant Staphylococcus aureus [MRSA], penicillin-resistant pneumococci)... [Pg.486]

Sulfate, amorphous red powder, uv max 283 nm (E 880). Freely sol in water. Slightly sol in methanol. Pract 2 cally inso in most other organic solvents. Aq solns have a bright orange color. Effective against penicillin-resistant pneumococci and staphylococci. The toxicity is comparable to that of penicillin. [Pg.36]

Most streptococci (but not enterococci) are very susceptible to the drug. However, penicillin-resistant viridans streptococci and S. pneumoniae are increasingly seen. Penicillin-resistant pneumococci also are resistant to third-generation cephalosporins and are especially common in children. More than 90% of staphylococcal isolates are now resistant to penicillin G, as are most strains of S. epidermidis and many strains of gonococci. With rare exceptions, meningococci are quite sensitive to penicillin G. [Pg.734]

Pneumococcal isolates with a minimal inhibitory concentration for penicillin G of greater than 2 pg/mL are highly resistant. Such strains are not killed by the concentrations of penicillin G or ampicillin that can be achieved in the cerebrospinal fluid. Nafcillin would be of value in a purulent meningitis suspected to be due to staphylococci but has minimal activity against penicillin-resistant pneumococci. Cefotaxime and ceftriaxone (not listed) are the most active cephalosporins against penicillin-resistant pneumococci, and the addition of vancomycin or rifampin is recommended in the case of highly resistant strains. As mentioned above, cefopera-zone does not readily cross the blood-brain barrier. The answer is (C). [Pg.383]

Blumberg HM, Rimland D. Nosocomial infection with penicillin-resistant pneumococci in patients with AIDS. J Infect Dis 1989 160 725-726. [Pg.86]

The following is the classical example. When sensitive pneumococci were cultivated in a medium to which an extract of penicillin-resistant pneumococci had been added, a proportion of the resulting organisms were penicillin-resistant and continued so on sub-culture. The transforming factor was foimd to be a DNA, and is the active part of a bacterial gene. In this way sensitive cells can be made resistant to penicillin without ever having been in contact with that drug (Hotchkiss, 1951), and streptomycin-resistance can be induced in the same way (Hotchkiss, 1955). [Pg.231]


See other pages where Penicillin-resistant pneumococci is mentioned: [Pg.221]    [Pg.988]    [Pg.992]    [Pg.1009]    [Pg.1063]    [Pg.172]    [Pg.490]    [Pg.1487]    [Pg.284]    [Pg.364]    [Pg.424]    [Pg.1932]    [Pg.2137]    [Pg.686]    [Pg.142]    [Pg.133]    [Pg.747]    [Pg.378]    [Pg.379]    [Pg.389]    [Pg.405]    [Pg.262]   
See also in sourсe #XX -- [ Pg.208 ]




SEARCH



Penicillin resistant

Penicillins resistance

Pneumococcus

© 2024 chempedia.info